| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |